Albireo Making Headway In Rare Pediatric Liver Diseases With IBAT Inhibition

Biotech hopes to launch a Phase III trial in the rare disorder PFIC before year’s end. It thinks its therapy could offer similar benefits to surgery in reducing pruritus and improving liver parameters.